{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:22:10Z","timestamp":1791397330582,"version":"4.3.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Human papilloma virus (HPV) types 6 and 11 account for 90 percent of anogenital warts (AGW). Assessment of a potential reduction of the incidence of AGW following introduction of HPV vaccines requires population-based incidence rates. The aim of this study was to estimate incidence rates of AGW in Germany, stratified by age, sex, and region. Additionally, the medical practitioner (gynaecologist, dermatologist, urologist etc.) who made the initial diagnosis of AGW was assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Retrospective cohort study in a population aged 10 to 79 years in a population-based healthcare insurance database. The database included more than 14 million insurance members from all over Germany during the years 2004-2006. A case of AGW was considered incident if a disease-free period of twelve months preceded the diagnosis. To assess regional variation, analyses were performed by federal state.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The estimated incidence rate was 169.5\/100,000 person-years for the German population aged 10 to 79 years. Most cases occurred in the 15 to 40 years age group. The incidence rate was higher and showed a peak at younger ages in females than in males. The highest incidence rates for both sexes were observed in the city-states Berlin, Hamburg and Bremen. In females, initial diagnosis of AGW was most frequently made by a gynaecologist (71.7%), whereas in males, AGW were most frequently diagnosed by a dermatologist (44.8%) or urologist (25.1%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Incidence of AGW in Germany is comparable with findings for other countries. As expected, most cases occurred in the younger age groups. The frequency of diagnoses of AGW differs between sexes and women and men receive treatment by doctors of different specialties.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-10-360","type":"journal-article","created":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T19:44:30Z","timestamp":1294256670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Incidence of anogenital warts in Germany: a population-based cohort study"],"prefix":"10.1186","volume":"10","author":[{"given":"Angela A","family":"Kraut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Schink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Schulze-Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael T","family":"Mikolajczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edeltraut","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,23]]},"reference":[{"issue":"Suppl 1","key":"1340_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jcv.2004.12.008","volume":"32","author":"JG Baseman","year":"2005","unstructured":"Baseman JG, Koutsky LA: The epidemiology of human papillomavirus infections. J Clin Virol. 2005, 32 (Suppl 1): 16-24. 10.1016\/j.jcv.2004.12.008.","journal-title":"J Clin Virol"},{"key":"1340_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1128\/JCM.44.2.571-579.2006","volume":"44","author":"WG Quint","year":"2006","unstructured":"Quint WG, Pagliusi SR, Lelie N, de Villiers EM, Wheeler CM, World Health Organization Human Papillomavirus DNA International Collaborative Study Group: Results of the First World Health Organization International Collaborative Study of Detection of Human Papillomavirus DNA. J Clin Microbiol. 2006, 44: 571-579. 10.1128\/JCM.44.2.571-579.2006.","journal-title":"J Clin Microbiol"},{"issue":"Suppl 5A","key":"1340_CR3","first-page":"13","volume":"102","author":"L Koutsky","year":"1997","unstructured":"Koutsky L: Epidemiology of genital human papillomavirus infection. Am J Med. 1997, 102 (Suppl 5A): 13-18.","journal-title":"Am J Med"},{"key":"1340_CR4","first-page":"101","volume":"42","author":"PR Hsueh","year":"2009","unstructured":"Hsueh PR: Human papillomavirus, genital warts, and vaccines. J Microbiol Immunol Infect. 2009, 42: 101-106.","journal-title":"J Microbiol Immunol Infect"},{"key":"1340_CR5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJF, Meijer CJLM, the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. N Engl J Med. 2003, 348: 518-527.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"1340_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.ogx.0000221010.82943.8c","volume":"61","author":"D Wiley","year":"2006","unstructured":"Wiley D, Masongsong E: Human papillomavirus: the burden of infection. Obstet Gynecol Surv. 2006, 61 (Suppl 1): 3-14. 10.1097\/01.ogx.0000221010.82943.8c.","journal-title":"Obstet Gynecol Surv"},{"key":"1340_CR7","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1056\/NEJMoa061760","volume":"356","author":"SM Garland","year":"2007","unstructured":"Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA, Females United to Unilaterally Reduce Endo\/Ectocervical Disease (FUTURE) I Investigators: Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007, 356: 1928-1943. 10.1056\/NEJMoa061760.","journal-title":"N Engl J Med"},{"key":"1340_CR8","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1086\/514964","volume":"27","author":"KR Beutner","year":"1998","unstructured":"Beutner KR, Reitano MV, Richwald GA, Wiley DJ: External genital warts: report of the American Medical Association Consensus Conference. AMA Expert Panel on External Genital Warts. Clin Infect Dis. 1998, 27: 796-806. 10.1086\/514964.","journal-title":"Clin Infect Dis"},{"key":"1340_CR9","unstructured":"Sexually transmitted disease quarterly report: gential warts and herpes simplex virus infection in the UK. Commun Dis Rep Weekly. 2003, 13:"},{"key":"1340_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bmj.38726.404120.7C","volume":"332","author":"JA Cassell","year":"2006","unstructured":"Cassell JA, Mercer CH, Sutcliffe L, Petersen I, Islam A, Brook MG, Ross JD, Kinghorn GR, Simms I, Hughes G, Majeed A, Stephenson JM, Johnson AM, Hayward AC: Trends in sexually transmitted infections in general practice 1990-2000: population based study using data from the UK general practice research database. BMJ. 2006, 332: 332-334. 10.1136\/bmj.38726.404120.7C.","journal-title":"BMJ"},{"key":"1340_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/eurpub\/ckn127","volume":"19","author":"X Castellsagu\u00e9","year":"2009","unstructured":"Castellsagu\u00e9 X, Cohet C, Puig-Tintor\u00e9 LM, Acebes LO, Salinas J, San Martin M, Breitscheidel L, R\u00e9my V: Epidemiology and cost of treatment of genital warts in Spain. Eur J Public Health. 2009, 19: 106-110.","journal-title":"Eur J Public Health"},{"key":"1340_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1471-2334-8-76","volume":"8","author":"P Hillemanns","year":"2008","unstructured":"Hillemanns P, Breugelmans JG, Gieseking F, B\u00e9nard S, Lamure E, Littlewood KJ, Petry KU: Estimation of the incidence of genital warts and the cost of illness in Germany: A cross-sectional study. BMC Infect Dis. 2008, 8: 76-10.1186\/1471-2334-8-76.","journal-title":"BMC Infect Dis"},{"key":"1340_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1071\/SHv4n4Ab53","volume":"4","author":"EL Conway","year":"2007","unstructured":"Conway EL, Stein AN, Pirotta MV, Garland S: Genital warts and associated health care use in general practice in Australia [abstract]. Sex Health. 2007, 4: 305-10.1071\/SHv4n4Ab53.","journal-title":"Sex Health"},{"key":"1340_CR14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/OLQ.0b013e318198de8c","volume":"36","author":"EV Kliewer","year":"2009","unstructured":"Kliewer EV, Demers AA, Elliott L, Lotocki R, Butler JR, Brisson M: Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada. Sex Transm Dis. 2009, 36: 380-386. 10.1097\/OLQ.0b013e318198de8c.","journal-title":"Sex Transm Dis"},{"key":"1340_CR15","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/01.olq.0000145851.76025.ad","volume":"31","author":"JE Koshiol","year":"2004","unstructured":"Koshiol JE, St Laurent SA, Pimenta JM: Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States. Sex Transm Dis. 2004, 31: 748-752. 10.1097\/01.olq.0000145851.76025.ad.","journal-title":"Sex Transm Dis"},{"key":"1340_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/sti.2008.030999","volume":"85","author":"F Marra","year":"2009","unstructured":"Marra F, Ogilvie G, Colley F, Kliewer E, Marra CA: Epidemiology and costs associated with genital warts in Canada. Sex Transm Infect. 2009, 85: 111-115. 10.1136\/sti.2008.030999.","journal-title":"Sex Transm Infect"},{"key":"1340_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/sti.2009.040188","volume":"86","author":"M Pirotta","year":"2010","unstructured":"Pirotta M, Stein AN, Conway EL, Harrison C, Britt H, Garland S: Genital warts incidence and healthcare resource utilisation in Australia. Sex Transm Infect. 2010, 86: 181-186. 10.1136\/sti.2009.040188.","journal-title":"Sex Transm Infect"},{"key":"1340_CR18","first-page":"33","volume":"20","author":"G Vittori","year":"2008","unstructured":"Vittori G, Matteelli A, Boselli F, Naldi L, Emberti Gialloreti L: A new approach to estimate genital warts incidence and prevalence in the Italian general female population. It J Gynaecol Obstet. 2008, 20: 33-42.","journal-title":"It J Gynaecol Obstet"},{"key":"1340_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/sti.2009.037788","volume":"85","author":"CK Fairley","year":"2009","unstructured":"Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, Bradshaw C: Rapid decline in presentations for genital warts after the implementation of a national quadrivalent human papillomavirus vaccination program for young women. Sex Transm Infect. 2009, 85: 499-502. 10.1136\/sti.2009.037788.","journal-title":"Sex Transm Infect"},{"key":"1340_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/pds.1545","volume":"17","author":"I Pigeot","year":"2008","unstructured":"Pigeot I, Ahrens W: Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations. Pharmacoepidemiol Drug Saf. 2008, 17: 215-223. 10.1002\/pds.1545.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1340_CR21","unstructured":"DIMDI Deutsches Institut f\u00fcr Medizinische Dokumentation und Information. [http:\/\/www.dimdi.de\/static\/de\/klassi\/diagnosen\/icd10\/htmlgm2006\/fr-icd.htm]"},{"key":"1340_CR22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/oxfordjournals.aje.a009523","volume":"147","author":"LE Daly","year":"1998","unstructured":"Daly LE: Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol. 1998, 147: 783-790.","journal-title":"Am J Epidemiol"},{"key":"1340_CR23","volume-title":"Regionalstatistischer Datenkatalog des Bundes und der L\u00e4nder 2008 (unver\u00f6ffentlichte Testversion)","author":"Regio-Stat","year":"2008","unstructured":"Regio-Stat: Regionalstatistischer Datenkatalog des Bundes und der L\u00e4nder 2008 (unver\u00f6ffentlichte Testversion). 2008, Statistische \u00c4mter des Bundes und der L\u00e4nder"},{"key":"1340_CR24","unstructured":"ESRI Mapping Centre. [http:\/\/mappingcenter.esri.com\/index.cfm?fa=ask.answers&q=541]"},{"key":"1340_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1467-8306.1971.tb00779.x","volume":"61","author":"GF Jenks","year":"1971","unstructured":"Jenks GF, Caspall FC: Error on Choroplethic Maps. Definition, Measurement, Reduction. Annals of the Association of American Geographers. 1971, 61: 217-244. 10.1111\/j.1467-8306.1971.tb00779.x.","journal-title":"Annals of the Association of American Geographers"},{"key":"1340_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/OLQ.0b013e3181971e4e","volume":"36","author":"MV Pirotta","year":"2009","unstructured":"Pirotta MV, Stein AN, Fairley CK, Morrow A, Conway EL, Chuah J, McCloskey J, McNulty A, Waddell R, Carter R, Garland S: Patterns of treatment of external genital warts in Australian sexual health clinics. Sex Transm Dis. 2009, 36: 375-379. 10.1097\/OLQ.0b013e3181971e4e.","journal-title":"Sex Transm Dis"},{"key":"1340_CR27","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1086\/375074","volume":"36","author":"RP Insinga","year":"2003","unstructured":"Insinga RP, Dasbach EJ, Myers ER: The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis. 2003, 36: 1397-1403. 10.1086\/375074.","journal-title":"Clin Infect Dis"},{"key":"1340_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.gyobfe.2006.12.010","volume":"35","author":"J Monsonego","year":"2007","unstructured":"Monsonego J, Breugelmans JG, Bouee S, Lafuma A, Benard S, Remy V: [Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France]. Gynecol Obstet Fertil. 2007, 35: 107-113. 10.1016\/j.gyobfe.2006.12.010.","journal-title":"Gynecol Obstet Fertil"},{"key":"1340_CR29","unstructured":"EPARs for authorised medicinal products for human use. [http:\/\/www.ema.europa.eu\/humandocs\/Humans\/EPAR\/gardasil\/gardasil.htm]"},{"key":"1340_CR30","unstructured":"Anlage 1 zur Richtlinie des Gemeinsamen Bundesausschusses \u00fcber Schutzimpfungen nach \u00a7 20 d Abs. 1 SGB V (Schutzimpfungs-Richtlinie\/SI-RL). [http:\/\/www.g-ba.de\/downloads\/83-691-171\/RL-Schutzimpfung-Anl1_2009-10-15.pdf]"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-10-360\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-10-360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T04:11:11Z","timestamp":1630469471000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-10-360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-10-360","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"27 July 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"360"}}